ChineseInvestors.com Inc. (CIIX) CEO Looks to Incr
Post# of 346
(Total Views: 281)
Posted On: 01/24/2020 7:02:36 PM
ChineseInvestors.com Inc. (CIIX) CEO Looks to Increase Profits by Selling New Hemp-Based CBD Products in Untapped Chinese Market
- CIIX subsidiary working to expand customer base with new hemp-based CBD products in 2020
- CEO focused on profits in 2020; plans to create strategic B2B, B2C divisions
- CBD Biotech unaffected by changing CBD-product regulations due to company’s focus on hemp-based CBD cosmetics
ChineseInvestors.com Inc. (OTCQB: CIIX) is a financial news media and content platform that provides information to the global Chinese-speaking community. After realizing the multitude of opportunities in the growing cannabis sector, especially concerning China’s nascent CBD market, CIIX has worked to cultivate an attractive lineup of products through its subsidiary CBD Biotech. While cannabis is still highly illegal in China, hemp-based CBD can be legally added to cosmetics. The team at CIIX recognizes the massive potential of the untapped Chinese CBD market.
CIIX has a user base of more than 100,000 people and has been around since 1999. Company CEO Warren Wang recently made an appearance on MoneyTV, during which he spoke about the company’s plans for 2020, many of which involve CBD Biotech. “The key is profit,” Wang stated in the interview (http://cnw.fm/nV4mH). “Secondly [we will] expand our market. Thirdly, we are going to divide the company divisions into B2B and B2C.”
Wang outlined plans to advertise via social media platforms such as TikTok in order to increase CIIX’s brand recognition and deepen its market penetration. In China, Wang explains, several different social media platforms have massive followings, as “young generations will use a lot of social media to know the products, know the commentary, and they will buy the products from Ecommerce platforms.”
Wang noted that China’s changing CBD laws can create volatility for CBD companies. However, those laws don’t apply to hemp-based CBD cosmetics, which are fully legal in China, Japan and the United States. Because CIIX is only involved in CBD cosmetics, the company remains unaffected by the changing regulations and is able to operate in a stable environment.
In 2020, CIIX will be launching new CBD cosmetic products, including an anti-aging product formulated to combat wrinkles. By targeting the Chinese-speaking community, CIIX has few competitors and plenty of room to grow. The company maintains its attention on the investment of both the distribution and the research and development of new CBD products.
CIIX is a diverse company driven by educational services and the sales of cosmetics, hemp wine and CBD. CIIX offers its audience of Chinese-speaking investors real-time market commentary, analysis and educational-related services in both traditional and simplified Chinese character language sets.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- CIIX subsidiary working to expand customer base with new hemp-based CBD products in 2020
- CEO focused on profits in 2020; plans to create strategic B2B, B2C divisions
- CBD Biotech unaffected by changing CBD-product regulations due to company’s focus on hemp-based CBD cosmetics
ChineseInvestors.com Inc. (OTCQB: CIIX) is a financial news media and content platform that provides information to the global Chinese-speaking community. After realizing the multitude of opportunities in the growing cannabis sector, especially concerning China’s nascent CBD market, CIIX has worked to cultivate an attractive lineup of products through its subsidiary CBD Biotech. While cannabis is still highly illegal in China, hemp-based CBD can be legally added to cosmetics. The team at CIIX recognizes the massive potential of the untapped Chinese CBD market.
CIIX has a user base of more than 100,000 people and has been around since 1999. Company CEO Warren Wang recently made an appearance on MoneyTV, during which he spoke about the company’s plans for 2020, many of which involve CBD Biotech. “The key is profit,” Wang stated in the interview (http://cnw.fm/nV4mH). “Secondly [we will] expand our market. Thirdly, we are going to divide the company divisions into B2B and B2C.”
Wang outlined plans to advertise via social media platforms such as TikTok in order to increase CIIX’s brand recognition and deepen its market penetration. In China, Wang explains, several different social media platforms have massive followings, as “young generations will use a lot of social media to know the products, know the commentary, and they will buy the products from Ecommerce platforms.”
Wang noted that China’s changing CBD laws can create volatility for CBD companies. However, those laws don’t apply to hemp-based CBD cosmetics, which are fully legal in China, Japan and the United States. Because CIIX is only involved in CBD cosmetics, the company remains unaffected by the changing regulations and is able to operate in a stable environment.
In 2020, CIIX will be launching new CBD cosmetic products, including an anti-aging product formulated to combat wrinkles. By targeting the Chinese-speaking community, CIIX has few competitors and plenty of room to grow. The company maintains its attention on the investment of both the distribution and the research and development of new CBD products.
CIIX is a diverse company driven by educational services and the sales of cosmetics, hemp wine and CBD. CIIX offers its audience of Chinese-speaking investors real-time market commentary, analysis and educational-related services in both traditional and simplified Chinese character language sets.
For more information, visit the company’s website at www.ChineseInvestors.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)